ethyl-pyrazin-2-ylmethyl-amine | 933750-32-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: ethyl-pyrazin-2-ylmethyl-amine
• 英文别名: N-(pyrazin-2-ylmethyl)ethanamine
• CAS: 933750-32-4
• 化学式: C₇H₁₁N₃
• 分子量: 137.184
• InChiKey: FPHBLTQIFQMUDE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  37.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• NOVEL SULFONAMIDE COMPOUNDS
  申请人：Aissaoui Hamed

  公开号：US20090275588A1

  公开（公告）日：2009-11-05

  The invention relates to novel sulfonamide compounds and their use as orexin receptor antagonists.

  这项发明涉及新型磺胺类化合物及其作为促觉醒素受体拮抗剂的用途。
• [EN] COMPOUNDS<br/>[FR] COMPOSÉS
  申请人：UNIV OXFORD INNOVATION LTD

  公开号：WO2019145718A1

  公开（公告）日：2019-08-01

  The present invention relates to compounds of Formula I as defined herein, and salts and solvates thereof. (I) The present invention also relates to pharmaceutical compositions comprising compounds of Formula(I), and to compounds of Formula(I) for use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which inhibition of a RAS-effector protein-protein interaction is implicated.

  本发明涉及本处所定义的化合物I的化合物，以及其盐和溶剂化物。本发明还涉及包括化合物I的药物组合物，以及用于治疗增生性疾病（如癌症）以及其他疾病或情况，其中涉及抑制RAS-效应蛋白-蛋白相互作用的化合物I。
• Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
  申请人：Incyte Corporation

  公开号：US10479795B2

  公开（公告）日：2019-11-19

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本申请涉及式 (I) 化合物： 或其药学上可接受的盐或立体异构体，它们是 PI3K-γ 的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病等疾病。
• BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE
  申请人：Gilead Sciences, Inc.

  公开号：EP3294732B1

  公开（公告）日：2019-09-25
• METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND
  申请人：Nishino Taito

  公开号：US20100266556A1

  公开（公告）日：2010-10-21

  An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy useful for treatment of various hematopoietic disorders is provided. A method for expanding hematopoietic stem cells and/or hematopoietic progenitor cells, which comprises culturing hematopoietic stem cells and/or hematopoietic progenitor cells ex vivo in the presence of a compound represented by the formula (I) (wherein X, Y, X, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are defined in the description), a tautomer or pharmaceutically acceptable salt of the compound or a solvate thereof.